C-Bridge hands Nu­ance Biotech $35M, open­ing doors to more Chi­na li­cens­ing deals

Chi­na’s pow­er­house pri­vate eq­ui­ty play­er C-Bridge Cap­i­tal is dish­ing out $35 mil­lion to ex­per­i­ment with a new part­ner­ship mod­el.

Its part­ners at Nu­ance Biotech an­nounced …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER